How does A2LA ensure accurate evaluation of both QMS and technical issues in its ISO 15189 assessments?
Is A2LA as competent to accredit clinical testing laboratories as they are to accredit other types of labs?
Does the ILAC peer evaluation of A2LA include an examination of A2LA’s ability to accredit clinical laboratories, specifically?
I have heard that A2LA and ILAC are “product–focused”, meaning that their emphasis is in the accreditation of product testing laboratories. Is this true?